Search Results 501-510 of 17253 for GLP-1 therapy
... associated oropharyngeal squamous cell carcinoma (HPV(+)OPSCC) who met criteria for de‐escalated radiation therapy, but received standard adjuvant treatment.
The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, and ...
1. During the early phases (phases 1 and 2) ... 1 trial. Phase 4 trials look ... Therapeutic modalities such as enzyme replacement therapy and gene therapy ...
... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...
The purpose of this study is to confirm the effectiveness and safety of terlipressin in the treatment of adult patients with hepatorenal syndrome (HRS) type 1.
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of therapy ...
... treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part 1) and dose expansion (Part 2). In Part 1, different ...
... therapy and allow for collaborative research. The ... Treatment Response of Locally-advanced Unresectable and Metastatic Pancreatic Cancer Therapies ... (1) Cohort 1 ...
... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.
The primary objective of this study is to determine the safety and tolerability of utilizing the insulin-like growth factor-1-methotrexate conjugate, 765IGF-MTX ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!